On March 11-13, 2024, ZETA Group held the 5th edition of their renowned ZETA Symposium in the heart of Styria, Austria. As in previous years, the symposium was attended by a large number of high-profile experts from the pharma and biotech sectors to learn about the newest trends and technologies. The motto of this year’s edition of the symposium, which took place at picturesque Schloss Seggau, was Pioneering the Future of Pharma & Biotech with AI Innovation.
Around 170 participants from all over the world were able to learn from inspiring lectures on the topics of AI, digitalization, sustainability, and agile project execution, and to discuss future developments and trends. As part of the symposium, ZETA organized an Innovation Path at their headquarters in Lieboch near Graz to demonstrate the most recent developments at ZETA and their partners in the areas of data-driven innovation, smart engineering and smart maintenance, integrated digital testing, and modularization/MTP.
Joined Forces: ZETA relies on INOSIM
ZETA and INOSIM have recently joined forces to establish INOSIM simulations and INOSIM Foresight as mainstay tools for digital-twin-first engineering and operations support across the complete life cycle. INOSIM is set to become a key pillar of ZETA digital innovation, and a central element of the ZETA Innovation Path was the counter on Data-Driven Innovation: Value-add of process simulations during plant design and operations at which ZETA simulation expert Alexander Schaller gave an overview of engineering and operations support with INOSIM digital twins and with INOSIM Foresight, our new platform for the predictive operations support for complex industrial plants.
At the closing of the event, ZETA Managing Director Andreas Marchler concluded: “With the symposium, we have established an event series of utmost radiance. Our lecturers and guests felt very comfortable, and the event was a complete success! The planning for the 6th edition of the symposium in March 2025 is already under way.”
Do you have any questions or would like to know more about this topic? Please contact us.
General Inquiries 
